Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$2.86B
Total Bought:
$800.77M
Total Sold:
$676.64M
Net Transaction:
+$124.14M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc4,571,6785,000,000+428,322$346.81M$511.50M17.90%+$164.69M
Arcellx Inc
COMMON STOCK
3,848,0954,000,000+151,905$212.38M$334.04M11.69%+$121.66M
argenx SEADR(ARGX)538,139480,374-57,765$231.42M$260.40M9.11%+$28.98M
Revolution Medicines, Inc.(RVMD)5,259,0895,314,089+55,000$204.11M$240.99M8.43%+$36.89M
Crinetics Pharmaceuticals In2,513,3022,516,686+3,384$112.57M$128.60M4.50%+$16.03M
Merus N V2,019,8142,454,917+435,103$119.51M$122.65M4.29%+$3.14M
Janux Therapeutics, Inc.(JANX)1,564,4522,400,574+836,122$65.53M$109.06M3.82%+$43.52M
Kura Oncology, Inc.(KURA)4,539,3814,331,321-208,060$93.47M$84.63M2.96%-$8.83M
Tarsus Pharmaceuticals, Inc.(TARS)2,435,4162,440,445+5,029$66.19M$80.27M2.81%+$14.07M
Edgewise Therapeutics, Inc.(EWTX)2,325,4492,789,172+463,723$41.88M$74.44M2.61%+$32.56M
Disc Medicine, Inc.(IRON)2,704,7181,497,720-1,206,998$121.90M$73.60M2.58%-$48.30M
Vaxcyte, Inc.(PCVX)627,202627,732+530$47.36M$71.73M2.51%+$24.37M
Viridian Therapeutics, Inc.(VRDN)2,896,3492,895,689-660$37.68M$65.88M2.31%+$28.20M
Olema Pharmaceuticals, Inc.(OLMA)7,903,6005,503,600-2,400,000$85.52M$65.71M2.30%-$19.80M
Arvinas, Inc.(ARVN)2,438,1492,339,961-98,188$64.90M$57.63M2.02%-$7.27M
Y-Mabs Therapeutics Inc3,870,5944,086,346+215,752$46.76M$53.74M1.88%+$6.98M
Cogent Biosciences, Inc.(COGT)3,624,3424,609,762+985,420$30.55M$49.79M1.74%+$19.23M
Vera Therapeutics, Inc.CL A(VERA)01,096,851+1,096,851$0$48.48M1.70%+$48.48M
MoonLake ImmunotherapeuticsCL A(MLTX)0931,480+931,480$0$46.97M1.64%+$46.97M
BeOne Medicines AGADR(ONC)0200,336+200,336$0$44.98M1.57%+$44.98M
Immatics N.V.SHS(IMTX)3,421,9653,904,862+482,897$39.76M$44.55M1.56%+$4.79M
Apogee Therapeutics Inc330,000701,817+371,817$12.99M$41.22M1.44%+$28.24M
Immunovant, Inc.(IMVT)1,362,8271,362,8270$35.98M$38.85M1.36%+$2.88M
Cullinan Therapeutics, Inc.(CGEM)1,542,8052,321,013+778,208$26.91M$38.85M1.36%+$11.95M
Spyre Therapeutics, Inc.(SYRE)01,267,581+1,267,581$0$37.28M1.30%+$37.28M
Pliant Therapeutics, Inc.(PLRX)03,104,486+3,104,486$0$34.80M1.22%+$34.80M
Keros Therapeutics, Inc.(KROS)0525,037+525,037$0$30.49M1.07%+$30.49M
Erasca, Inc.(ERAS)7,250,00010,668,141+3,418,141$17.11M$29.12M1.02%+$12.01M
Oruka Therapeutics, Inc.(ORKA)0719,660+719,660$0$17.64M0.62%+$17.64M
Perspective Therapeutics, Inc.(CATX)919,692919,6920$9.17M$12.28M0.43%+$3.11M
COMPASS Pathways plcADS(CMPS)2,335,9261,160,000-1,175,926$14.11M$7.31M0.26%-$6.80M
Acrivon Therapeutics Inc659,7240-659,724$3.83M$0—-$3.83M
ALX Oncology Holdings Inc.(ALXO)1,575,6050-1,575,605$9.50M$0—-$9.50M
Ascendis Pharma A/SADR(ASND)664,3070-664,307$90.60M$0—-$90.60M
BridgeBio Pharma, Inc.(BBIO)1,089,4920-1,089,492$27.60M$0—-$27.60M
Cerevel Therapeutics Hldng I2,330,5080-2,330,508$95.29M$0—-$95.29M
Legend Biotech CorporationADS(LEGN)1,203,3080-1,203,308$53.29M$0—-$53.29M
Sarepta Therapeutics, Inc.(SRPT)947,5740-947,574$149.72M$0—-$149.72M
TScan Therapeutics, Inc.(TCRX)353,8860-353,886$2.07M$0—-$2.07M
Verona Pharma PlcADS721,0870-721,087$10.43M$0—-$10.43M
Vor Biopharma Inc.(VOR)6,457,2930-6,457,293$6.46M$0—-$6.46M
Xenon Pharmaceuticals Inc.(XENE)2,043,2800-2,043,280$79.67M$0—-$79.67M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q3 2024 | TickerTrail